Radar degli Studi Clinici

beta

Avanzata

Trial Radar IA Candidato allo studio o Paziente Assistente del Paziente Professionista Sanitario Professionista Biotech Investitore Biotech Ricercatore Altro
	Mostrando gli studi clinici per Diabete che corrispondono al luogo: Texas. Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.

Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).

Cerca per parole chiave...

Cerca per località, centro...

Titolo dello studio	Stato
Continuous Glucose Monitoring in Critically Ill NCT00707434	TerminatoRisultati pubblicati
FreeStyle Libre 3 Continuous Glucose Monitoring System NCT05962710	Terminato
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes (DIaMonD) NCT02282397	Completato
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics NCT04436822	CompletatoRisultati pubblicati
PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days NCT03808376	CompletatoRisultati pubblicati
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy NCT05430204	CompletatoRisultati pubblicati
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System NCT04794478	Completato
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes NCT06719531	Ritirato
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features NCT05131139	Sconosciuto
Continuous Monitoring and Control of Hypoglycemia (COACH) NCT03340831	Sconosciuto
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) (COMMITED) NCT03620357	Completato
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System NCT04645641	Sconosciuto
Evaluation of the Accuracy of an Implanted Glucose Sensor (PRECISEII) NCT02647905	CompletatoRisultati pubblicati
PERL Continuous Glucose Monitoring (CGM) Study NCT03334318	Completato
CGM for Management of Type 2 Diabetes in Pregnancy (CGM2) NCT06628453	In arruolamento
Post Approval Study of the Eversense® Continuous Glucose Monitoring (PAS) NCT03908125	CompletatoRisultati pubblicati
Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System NCT00920881	Completato
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes NCT04230694	Attivo, non in arruolamento
Study of an Interstitial Fluid Glucose Sensor NCT05251116	Completato
Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes NCT04540536	CompletatoRisultati pubblicati
G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator NCT02696252	Completato
Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices NCT05124405	Attivo, non in arruolamento
Biolinq Safety and Effectiveness Trial NCT06229743	CompletatoRisultati pubblicati
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) NCT04605991	CompletatoRisultati pubblicati
Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems NCT02283411	CompletatoRisultati pubblicati
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients (inRange) NCT04075513	CompletatoRisultati pubblicati
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG) NCT01030341	CompletatoRisultati pubblicati
Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) NCT03566693	Completato
Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes (GLIMPSE) NCT01818557	Completato
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) (CITY) NCT03263494	Completato
Eversense® Non-adjunctive Use Post Approval Study (NA-PAS) NCT04836546	Attivo, non in arruolamento
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children (SUCCEED2) NCT06604871	Completato
HbA1c Variation Study NCT05189938	Completato
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM NCT05714059	CompletatoRisultati pubblicati
Pivotal Omnipod Horizon™ Automated Glucose Control System NCT04196140	CompletatoRisultati pubblicati
Simplified Onboarding in Adults With Type 2 Diabetes (SIMPLEUSE) NCT07070830	Completato
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus (CPEX-011) NCT00850096	CompletatoRisultati pubblicati
An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes NCT07276776	Attivo, non in arruolamento
Omnipod Horizon™ Automated Glucose Control System Preschool Cohort NCT04476472	CompletatoRisultati pubblicati
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus (Soli-CGM) NCT05114590	CompletatoRisultati pubblicati
Omnipod 5 System Compared to Pump Therapy NCT05409131	CompletatoRisultati pubblicati
Permissive Intrapartum Glucose Control NCT05553275	Completato
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes NCT05904743	Completato
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214	CompletatoRisultati pubblicati
ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community NCT06028503	In arruolamento
6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes (PRESCHOOL) NCT00993473	CompletatoRisultati pubblicati
Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes (STRIVE) NCT06865989	Completato
Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes NCT03466398	Ritirato
Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin NCT02429258	CompletatoRisultati pubblicati
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes (STAR1) NCT00211510	CompletatoRisultati pubblicati

Radar degli Studi Clinici

Fase

Tipo

Tipo di studio

Fascia d'età

Sesso

Placebo

Fase

Tipo

Tipo di studio

Fascia d'età

Sesso